Histological Changes in Ovary Treated with Dexamethasone and Cefotaxime Sodium

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 59

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_ARCHRAZI-77-3_008

تاریخ نمایه سازی: 6 دی 1402

Abstract:

Dexamethasone (DEX), which is a corticosteroid hormone (glucocorticoid), has been used to treat different conditions, such as immune system disorders, certain skin and eye disorders, as well as breathing problems. Cefotaxime sodium, also called Claforan, is synthesized from a naturally occurring material (semisynthetic). It is a broad-spectrum cephalosporin antibiotic that could be utilized for parenteral administration. The present study aimed to investigate histological changes occurring in the tissues and cells of the rats’ ovary (primordial, primary, secondary, antral, and mature follicle) treated with Cefotaxime sodium, as well as DEX, and evaluate the impacts of these medications on animals’ fertility. In total, ۴۰ female adult Wistar rats were divided into four groups (n=۱۰). The control group received ۰.۵ ml/kg of distilled water daily for five days as a placebo. The second group was injected with ۰.۵ mg/kg of DEX daily for five days. The same amount of Claforan (۰.۵ mg/kg) was injected into the third group daily for five days, and the fourth group received ۰.۵ mg/kg of both Claforan and DEX daily for five days. Afterward, the ovaries were prepared for histological examination. The ImageJ image analysis system was used to detect morphometric parameters and calculate the area of these organs. The findings of the present study showed that the DEX and Claforan brought changes to the ovarian area and the number of follicles. The ovarian area significantly increased (P<۰.۰۰۷) in the DEX-treated group (mean±SEM=۷.۳±۰.۵ mm۲), compared to the control group (mean±SEM=۴.۶±۰.۲۰ mm۲). However, DEX was found to decrease body weight. Furthermore, the ovarian area significantly increased in the Claforan-treated group (mean±SEM=۸.۶±۰.۶ mm۲); however, their body weight significantly decreased (P<۰.۰۰۸), in comparison with the control and DEX-treated groups. The combination treatment (i.e., DEX + Cefotaxime sodium) significantly increased (P<۰.۰۰۹) the area of ovaries even more, compared to single treatments (mean±SEM=۹.۶±۰.۴ mm۲). Overall, both DEX and Claforan brought histological changes to ovaries. However, the effect of DEX on ovaries was less than that of Claforan. The concurrent administration of both medications was found to have more significant effects on rats’ ovaries.

Authors

S Omairi

Department of Anatomy and Biology, College of Medicine, University of Wasit, Al Kut, Iraq

K Alyodawi

Department of Anatomy and Biology, College of Medicine, University of Wasit, Al Kut, Iraq

T Al Qaisi

Department of Pathology and Forensic Medicine, College of Medicine, University of Wasit, Al Kut, Iraq

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Mukherjee S, Sanghamita R, Bhartiya N. Ovarian maldescent: a case ...
  • Wylie L. Essential Anatomy & Physiology in Maternity Care: Elsevier ...
  • Myers M, Britt KL, Wreford NGM, Ebling FJ, Kerr JB. ...
  • Anderson R, Themmen A, -Qahtani AA, Groome N, Cameron D. ...
  • Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids—new mechanisms for ...
  • Ploner C, Schmidt S, Presul E, Renner K, Schröcksnadel K, ...
  • Gupta B. Role of dexamethasone in peri-operative anesthesia manage-ment: A ...
  • Grad I, Picard D. The glucocorticoid responses are shaped by ...
  • Van Zanten A, Oudijk M, Nohlmans‐Paulssen M, Van der Meer ...
  • Fahmy MA, Diab KA. In vivo genotoxicity studies of cefotaxime. ...
  • Rivkin AM. Hepatocellular enzyme elevations in a patient receiving ceftriaxone. ...
  • Peker E, Cagan E, Dogan M. Ceftriaxone-induced toxic hepatitis. World ...
  • Eason JM, Dodd SL, Powers SK. Use of Anabolic Steroids ...
  • Amar M, Shama IA, Enaia A, Hind A, Hager A. ...
  • De Vos P, Saladin R, Auwerx J, Staels B. Induction ...
  • Maciel S, Chamberlain C, Wettemann R, Spicer L. Dexamethasone influences ...
  • Roy SK, Wang J, Yang P. Dexamethasone inhibits transforming growth ...
  • Lv F, Wan Y, Chen Y, Pei L, Luo D, ...
  • Lee VH, Lee LT, Chow BK. Gonadotropin‐releasing hormone: regulation of ...
  • de Figueiredo Moraes E, Teixeira VW, Teixeira ÁAC, da Silva ...
  • Tayade PM, Jagtap SA, Borde S, Chandrasekar N, Joshi A. ...
  • نمایش کامل مراجع